HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

Diğer sürümleri göster (1)

This study investigated the effects of 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (IOX3), a selective small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylases, on mouse brains subject to transient focal cerebral ischaemia. Male, 8- to 12-week-old C57/B6 mice w...

Detaylı Bibliyografya
Asıl Yazarlar:	Chen, R, Ogunshola, O, Yeoh, K, Jani, A, Papadakis, M, Nagel, S, Schofield, C, Buchan, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2014

Benzer Materyaller

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
Yazar:: Chen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice.
Yazar:: Chen, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
Yazar:: Maria Savyuk, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Regulation of HIF: prolyl hydroxylases.
Yazar:: Stolze, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
Yazar:: Singh, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.
Yazar:: Sutherland, B, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia
Yazar:: Sutherland, B, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Yazar:: Mole, D, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
Yazar:: McNeill, L, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
Yazar:: Schlemminger, I, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.
Yazar:: Nagel, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats
Yazar:: Nagel, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Yazar:: Flashman, E, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Therapeutic manipulation of the HIF hydroxylases.
Yazar:: Nagel, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Yazar:: Cockman, M, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
Yazar:: Matthew E Cockman, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Yazar:: Tuckerman, JR, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Yazar:: Chan, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Yazar:: Chowdhury, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
Yazar:: Richardson, NL, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Yazar:: Rasheduzzaman Chowdhury, ve diğerleri
Baskı/Yayın Bilgisi: (2016-08-01)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
Yazar:: Yeh, TL, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
Yazar:: Moritz J. Strowitzki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
Yazar:: Yeoh, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
Yazar:: Wijeyekoon, JB
Baskı/Yayın Bilgisi: (2013)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Yazar:: Andrey A. Poloznikov, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS
Yazar:: Tan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Inhibition of a viral prolyl hydroxylase
Yazar:: Langley, G, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
Yazar:: Astuti, D, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia.
Yazar:: Nagel, S, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Relative Contribution of Prolyl Hydroxylase-Dependent and -Independent Degradation of HIF-1alpha by Proteasomal Pathways in Cerebral Ischemia
Yazar:: Yomna Badawi, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Yazar:: Mayer, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
Yazar:: Holt-Martyn, JP, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
Yazar:: Lippl, K
Baskı/Yayın Bilgisi: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
Yazar:: Masson, N, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
Yazar:: Takahiro Kambara, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
Yazar:: Kiichi Hirota
Baskı/Yayın Bilgisi: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
Yazar:: Kilian B. Kennel, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
Yazar:: Savyuk, Maria Olegovna, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)